Akero Therapeutics, Inc. (AKRO)

Last Closing Price: 46.94 (2025-08-28)

Expense Ratio (Quarterly)

Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned

Akero Therapeutics, Inc. (AKRO) Expense Ratio data is not available.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
--
$-70.50M
--
--
$80.87M
$-80.87M
$10.37M
$-70.50M
$-70.50M
$-70.50M
$-70.50M
$-70.50M
$-70.50M
$-80.87M
$-83.55M
81.72M
81.72M
$-0.86
$-0.86
Balance Sheet Financials
$764.60M
--
$344.55M
$1.11B
$60.40M
$22.56M
$22.93M
$83.33M
$1.03B
$1.03B
$1.03B
79.92M
Cash Flow Statement Financials
$-115.91M
$-402.84M
$398.96M
$340.24M
$220.45M
$-119.79M
$17.84M
--
--
Fundamental Metrics & Ratios
12.66
--
--
0.02
0.04
--
--
--
--
--
--
$-115.91M
--
Expense Ratio
--
--
--
--
--
--
-6.87%
-6.87%
-6.36%
-6.73%
$12.84
$-1.42
$-1.42